日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comparative Effectiveness of ACE Inhibitors and Angiotensin Receptor Blockers for Cardiovascular Disease Prevention in People Living with HIV and Hypertension

ACE抑制剂与血管紧张素受体阻滞剂在HIV合并高血压患者心血管疾病预防中的疗效比较

Forzy, Tom; Yebyo, Henock G; Lucas, Gregory M; Günthard, Huldrych F; Lesko, Catherine R; Marconi, Vincent C; Sterling, Timothy R; Silverberg, Michael J; Karris, Maile Y; Horberg, Michael A; Napravnik, Sonia; Althoff, Keri N; Puhan, Milo A

Statins for primary prevention of cardiovascular events in people with HIV: target trial and modelling study

他汀类药物用于HIV感染者心血管事件一级预防:目标试验和建模研究

Yebyo, Henock G; Guenthard, Huldrych F; Rehfuess, Eva A; Serra, Nicola; Haile, Sarah R; Senn, Oliver; Lucas, Gregory M; Langselius, Oliver; Thorne, Jennifer E; Marconi, Vincent C; Coburn, Sally B; Lang, Raynell; Colasanti, Jonathan A; Silverberg, Michael J; Napravnik, Sonia; Loutfy, Mona; Karris, Maile; Sterling, Timothy R; Burkholder, Greer A; Althoff, Keri N; Puhan, Milo A

GLP-1 receptor agonists for weight reduction in people living with obesity but without diabetes: a living benefit-harm modelling study

GLP-1受体激动剂用于肥胖但无糖尿病人群的减重:一项基于生活获益-危害模型的研究

Moll, Hannah; Frey, Eliane; Gerber, Philipp; Geidl, Bettina; Kaufmann, Marco; Braun, Julia; Beuschlein, Felix; Puhan, Milo A; Yebyo, Henock G

Epidemiology of pre-cancerous cervical lesion and risk factors among adult women in Tigray, Ethiopia

埃塞俄比亚提格雷州成年女性宫颈癌前病变的流行病学及危险因素

Abera, Gerezgiher B; Yebyo, Henock G; Hailekiros, Haftamu; Niguse, Selam; Berhe, Yibrah; Gigar, Goitom; Asmelash, Tsehaye; Goba, Gelila

Survival modelling and cost-effectiveness analysis of treatments for newly diagnosed metastatic hormone-sensitive prostate cancer

对新诊断的转移性激素敏感性前列腺癌的治疗进行生存模型构建和成本效益分析

Barbier, Michaela C; Tomonaga, Yuki; Menges, Dominik; Yebyo, Henock G; Haile, Sarah R; Puhan, Milo A; Schwenkglenks, Matthias

Systematic early versus late mobilization or standard early mobilization in mechanically ventilated adult ICU patients: systematic review and meta-analysis

系统性早期活动与晚期活动或标准早期活动在机械通气成人ICU患者中的比较:系统评价和荟萃分析

Menges, Dominik; Seiler, Bianca; Tomonaga, Yuki; Schwenkglenks, Matthias; Puhan, Milo A; Yebyo, Henock G

Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study

全球范围内启动他汀类药物用于心血管疾病一级预防的风险阈值存在差异:一项获益-风险平衡模型研究

Yebyo, Henock G; Zappacosta, Sofia; Aschmann, Hélène E; Haile, Sarah R; Puhan, Milo A

Net benefit of statins for primary prevention of cardiovascular disease in people 75 years or older: a benefit-harm balance modeling study

他汀类药物在75岁及以上人群心血管疾病一级预防中的净获益:一项获益-风险平衡模型研究

Yebyo, Henock G; Aschmann, Hélène E; Menges, Dominik; Boyd, Cynthia M; Puhan, Milo A

Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contexts

他汀类药物指南是否应考虑患者偏好?在撒哈拉以南非洲和欧洲地区,了解患者对他汀类药物用于心血管疾病一级预防的获益和风险结果的偏好。

Yebyo, Henock G; Aschmann, Hélène E; Yu, Tsung; Puhan, Milo A